Yoshiyuki Yazaki Selected Research

Atrial Fibrillation

10/2021

Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiyuki Yazaki Research Topics

Disease

10	Heart Failure 05/2022 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2011 - 01/2011
1	Rupture 01/2023
1	Aneurysm (Aneurysms) 01/2023
1	Atrioventricular Block 01/2022
1	Coronary Disease (Coronary Heart Disease) 10/2021
1	Atrial Fibrillation 10/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2011
1	Death (Near-Death Experience) 01/2011
1	Chronic Renal Insufficiency 01/2011

Drug/Important Bio-Agent (IBA)

7	trimethyloxamine (trimethylamine N-oxide)IBA 05/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2011
1	Fluorocarbon PolymersIBA 01/2023
1	RivaroxabanIBA 10/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Acetylcarnitine (Alcar)IBA 01/2021
1	Natriuretic PeptidesIBA 01/2020
1	HDL LipoproteinsIBA 09/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2011
1	oxidized low density lipoproteinIBA 09/2011

Therapy/Procedure

2	Stents 01/2023 - 01/2011
1	Transcatheter Aortic Valve Replacement 01/2022
1	Percutaneous Coronary Intervention 01/2011